Enea (Q4 Review) - EBITDA beat of 9%—but anaemic 1% organic growth keeps shares becalmed
Redeye’s analyst just published a Research Update on Enea.
Click here to read the article
Make sure to add Enea to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se